Vyne Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $130 | $169 | $69 | $202 |
Gross Profit | -440 | 169 | 69 | 202 |
EBITDA | -4,179 | -7,420 | -7,536 | -9,191 |
EBIT | -4,956 | -7,426 | -7,542 | -9,197 |
Net Income | -4,837 | -7,280 | -5,755 | -8,611 |
Net Change In Cash | 130 | 169 | 69 | 202 |
Free Cash Flow | -3,764 | -7,096 | -10,803 | -11,461 |
Cash | 24,027 | 19,346 | 22,047 | 28,209 |
Basic Shares | 42,768 | 42,745 | 42,759 | 42,673 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $570 | $501 | $424 | $477 |
Gross Profit | 501 | 424 | 477 | |
EBITDA | -26,732 | -43,633 | -29,258 | -34,223 |
EBIT | -43,637 | -29,003 | -34,295 | |
Net Income | -26,483 | -39,834 | -28,452 | -23,210 |
Net Change In Cash | 570 | 501 | 424 | 477 |
Free Cash Flow | -33,124 | -34,089 | -25,341 | -29,200 |
Cash | 24,027 | 19,926 | 30,620 | 30,908 |
Basic Shares | 42,768 | 42,589 | 10,273 | 3,185 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.17 |
2025-06-30 | -$0.13 |
2025-03-31 | -$0.20 |
2024-12-31 | -$0.28 |
